IVD Reagent Raw Material Market
Request Sample Report
IVD Reagent Raw Material Market Size and Growth
The IVD Reagent Raw Material market is poised for significant growth, driven by increasing diagnostic testing demand and technological advancements. The market size is projected to reach approximately $4 billion by 2025, reflecting a compound annual growth rate of over 6%. Rising healthcare expenditures and trends in personalized medicine further support this expansion.
Companies Covered
(Covid 19 Impact Covered)
◍ Thermo Fisher
◍ Promega
◍ Roche
◍ Bio-Rad
◍ Takara Bio
◍ Agilent
◍ Qiagen
◍ Fapon Biotech
◍ TOYOBO Biotech
◍ Vazyme
◍ Fapon Biotech Inc
◍ New England Biolabs
The IVD reagent raw material market is competitive, with key players like Thermo Fisher, Roche, and Qiagen providing essential components for diagnostic applications. These companies innovate and expand product lines, enhancing testing accuracy and efficiency, while driving market growth. Revenue highlights include:
- Roche: ~$60 billion (2022)
- Thermo Fisher: ~$39 billion (2022)
- Bio-Rad: ~$2 billion (2022)
Request Sample Report
Market Segmentation
By Application By Product
Hospital
Research Institutions
Others
Request Sample Report
Antigens and Antibodies
Enzymes and Coenzymes
Other
Market Growth
Request Sample Report
$ X Billion USD
